EN
HI
Remus Pharmaceuticals share price chart
Remus Pharmaceuticals Share Key Metrics
Volume
17800.00
Market Cap
1133.21 CR
LTQ@LTP
100@961.65
ATP
966.49
Var Margin
53.5 %
Circuit Range
769.35-1153.95
Delivery %
85.02 %
Value
1.72 CR
ASM/GSM
No
Market Lot
100
Summary
REMUS stock price is ₹961.65 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹945.10 and ₹987.50, while Remus Pharmaceuticals share price 52 week high low is ₹580.00 & ₹987.50.
In terms of trading activity, REMUS share price has recorded a volume of 17,800 shares. The Remus Pharmaceuticals has a market cap of ₹11784000. The stock’s Average Traded Price (ATP) stands at ₹966.49, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹961.65.
The Remus Pharmaceuticals upper circuit limit is ₹1153.95 & The Remus Pharmaceuticals lower circuit limit is ₹769.35, with a Value of ₹1.72 CR. The Delivery Percentage for the day is 85.02%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹100.
Remus Pharmaceuticals Fundamentals
P/E Ratio
30.64
P/B Ratio
3.23
Div. Yield
0.1
Sector P/E
59.01
Sector P/B
2.17
Sec. Div. Yield
75.6
Remus Pharmaceuticals Resistance and Support
Pivot 931.95
Resistance
First Resistance
984.9
Second Resistance
1020
Third Resistance
1072.95
Support
First Support
896.85
Second Support
843.9
Third Support
808.8
Remus Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 956 | 961.65 | 1.25% | 987.5 | 945.1 |
| Thu Aug 20 2026 | 883 | 949.79 | 8.06% | 967.04 | 879 |
| Wed Aug 19 2026 | 890 | 878.95 | -1.66% | 890 | 856 |
Remus Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-20 | Audited Results |
| 2025-11-10 | Quarterly Results & Interim Dividend |
| 2025-05-17 | Audited Results |
| 2024-11-09 | Quarterly Results & Interim Dividend |
Remus Pharmaceuticals Management
| Name | Position |
|---|---|
| Deval Bakulkumar Patel | Company Secretary & Compliance Officer |
| Arpit Deepakkumar Shah | Managing Director |
Remus Pharmaceuticals Similar Stocks
Satia Industries Ltd.
58.68
0.97 (1.68%)
Arisinfra Solutions Ltd.
143.41
4.09 (2.94%)
Orient Technologies Ltd.
243.65
0.50 (0.21%)
Antony Waste Handling Cell Ltd.
383.85
2.70 (0.71%)
Arrow Greentech Ltd.
713.15
20.80 (3.00%)
Jaro Institute of Technology Management and Research Ltd.
443.10
3.05 (0.69%)
Prizor Viztech Ltd.
971.75
46.25 (5.00%)
TAC Infosec Ltd.
417.85
-6.90 (1.62%)
Remus Pharmaceuticals FAQs
The Buying Price of Remus Pharmaceuticals share is 961.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Remus Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Remus Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Remus Pharmaceuticals shares is 30.64. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Remus Pharmaceuticals shares is 3.23. Useful to assess the stock's value relative to its book value.
To assess Remus Pharmaceuticals’s valuation compare Sector P/E, P/B which are 59.01 & 2.17 with sector averages, along with growth rates and financial metrics.
The Market Cap of Remus Pharmaceuticals is 1133.21 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Remus Pharmaceuticals share price is 987.50 & 580.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Remus Pharmaceuticals belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
